The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology

British Journal of Ophthalmology

Volumn 80, Issue 5, 1996, Pages 480-485

  Koay, Peter ^a  

^a DARLINGTON MEMORIAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CORTICOSTEROID; DICLOFENAC; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ALLERGIC CONJUNCTIVITIS; ANALGESIA; ARACHIDONIC ACID METABOLISM; BURN; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EXCIMER LASER; EYE INFLAMMATION; HUMAN; MIOSIS; OPHTHALMOLOGY; PRIORITY JOURNAL; PSEUDOPHAKIA; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0029893267     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.5.480     Document Type: Review

References (98)

1. Rosenbaum JT. Towards cytokine insight in sight. Br J Ophthalmol 1995; 79: 970-1.
2. Bhattacherjee P. The role of arachidonate metabolites in ocular inflammation. The ocular effects of prostaglandins and other eicosanoids. New York: Alan R Liss, 1989: 211-27.
3. Van Husen H. Topical treatment of anterior ocular diseases with diclofenac Na eye drops. Klin Monatsbl Augenheilkd 1986; 188: 615-9.
4. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36: 259-84.
5. Srobel J. Concentration of locally applied indomethacin eye drops for the inhibition of prostaglandin synthesis in the eye. Ophthalmology 1991; 202: 43-7.
6. Frucht-Pery J, Zauberman H. The effect of indomethacin on prostaglandin E2 in human cornea and conjunctiva. Arch Ophthalmol 1992; 110: 343-5.
7. Spiess BM, Mathis GA, Franson KL, Leber A. Kinetics of uptake and effects of topical indomethacin application on protein concentration in the aqueous humor of dogs. Am J Vet Res 1991; 52: 1159-63.
8. Sanders DR, Kraff MC, Goldstick B. Aqueous penetration of oral and topical indomethacin in humans. Arch Ophthalmol 1983; 101: 1614-6.
9. Anderson JA, Chen CC, Vita JB. Disposition of topical flurbiprofen in normal and aphakic rabbit eyes. Arch Ophthalmol 1982; 100: 642-5.
10. Ling TL, Comb DL. Ocular bioavailability and tissue distribution of ketorolac tromethamine in rabbits. J Pharm Sci 1987; 76: 289-94.
11. Goa KL, Chrisp P. Ocular diclofenac: a review of its pharmacology and clinical use in cataract surgery and potential in other inflammatory ocular conditions. Drugs Aging 1992; 2: 478-9.
12. Voltaren ophthalmic prescribing information 11/93, CS665633.
13. Fraser-Smith EB, Matthews TR. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits. J Ocular Pharmacol 1988; 4: 101-9.
14. Kana JS, Wiederholt M. Corticosteroid and the active ion transport of the isolated human lens. Ann Ophthalmol 1984; 16: 1034-9.
15. Hic J, Gigon S, Leuenberger PM. Comparison of the anti-inflammatory effect of dexamethasone and diclofenac ophthalmic preparations. Klin Monatsbl Augenheilkd 1984; 184: 494-8.
16. Geiser DK, Hodapp E, Goldberg I, Kass MA, Becker B. Flurbiprofen and intraocular pressure. Ann Ophthalmol 1981; 13: 831-3.
17. Strelow SA, Sherwood MB, Broncato LJB, Napier A, Driebe WT, Guy JR, et al. The effect of diclofenac sodium ophthalmic solution on intraocular pressure following cataract extraction. Ophthalmic Surg 1992; 23: 170-5.
18. Trousdale MD, Barlow WE, McGuigan LJB. Assessment of diclofenac on herpes keratitis in rabbit eyes. Arch Ophthalmol 1989; 107: 1664-6.
19. Ashton N, Cook C. Effect of cortisone on healing of corneal wounds. Br J Ophthalmol 1951; 35: 708.
20. Srinivasan BD. Comeal reepithelialization and anti-inflammatory agents [Review]. Trans Am Ophthalmol Soc 1982; 80: 758-822.
21. Loya N, Bassage S, Vyas S, del Cerro M, Park SB, Aquavella JV. Topical diclofenac following excimer laser effect on comeal sensitivity and wound healing in rabbits. J Refract Corneal Surg 1994; 10: 423-7.
22. Hersh PS, Rice BA, Baer JC, Wells PA. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol 1990; 108: 577-83.
23. Henahan JF. Wounds destabilised by steroids more than by incision sutures. Ophthalmology Times 1992; 8.
24. McCarey BE, Napalkov JA, Pippen PA, Reaves TA. Corneal wound healing strength with topical anti-inflammatory drugs. Invest Ophthalmol Vis Sci 1993; 34: 1321.
25. Miller D, Gruenberg P, Miller R, Bergamini MVW. Topical flurbiprofen or prednisolone: effect on corneal wound healing in rabbits. Arch Ophthalmol 1981; 99: 681-2.
26. Masket S. Comparison of the effect of topical corticosteroid and non-steroidals on postoperative corneal astigmatism. J Cataract Refract Surg 1990; 16: 715-8.
27. Flach AJ, Lavelle CJ, Olander KW, Retzlaff JA, Sorenson LW. The effect of ketorolac tromethamine solution 0.5% in reducing postsurgical inflammation after cataract extraction and intraocular lens implantation. Ophthalmology 1988; 95: 1279-84.
28. Flach AJ, Graham J, Kruger L, Stegman RC, Tanenbaum L. Quantitative assessment of postsurgical breakdown of the blood aqueous barrier following administration of ketorolac tromethamine solution: a double-masked, paired comparison with vehicle-placebo solution study. Arch Ophthalmol 1988; 106: 344-7.
29. Flach AJ, Jaffe NS, Akers WA. The effect of ketorolac tromethamine in reducing postoperative inflammation: a double-masked parallel comparison with dexamethasone. Ann Ophthalmol 1989; 21: 407-11.
30. Flach AJ, Kraff MC, Sanders DR, Tanenbaum L. The quantitative effect of 0.5% ketorolac tromethamine solution and dexamethasone sodium phosphate solution on the post-surgical blood-aqueous barrier. Arch Ophthalmol 1988; 106: 480-3.
31. Vickers FF, McGuigan LJB, Ford C, Wysowskyj H, Mellars K, Koester J, et al. The effect of diclofenac sodium ophthalmic on the treatment of post-operative inflammation. Invest Ophthalmol Vis Sci 1991; 32: 793.
32. Kraff MC, Martin RG, Nuemann AC, Weinstein AJ. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg 1994; 20: 138-44.
33. Brennan KM, Brown RM, Roberts CW. A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation. Insight 1993; 18: 8-9, 11.
34. Kraff MC, Sanders DR, McGuigan L, Raanan MG. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study. Arch Ophthalmol 1990; 108: 380-3.
35. Hotchkiss ML, Robin AL, Pollack IP, Quigley HA. Nonsteroidal anti-inflammatory agent after argon laser trabeculoplasty. A trial with flurbiprofen and indomethacin. Ophthalmology 1984; 91: 969-76.
36. Weinreb RN, Robin AL, Baerveldt G, Drake MV, Blumenthal M, Wilensky J. Flurbiprofen pre-treatment in argon laser trabeculoplasty for primary open-angle glaucoma. Arch Ophthalmol 1984; 102: 1629-32.
37. Goethals M, Missotten L. Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eye drops in inflammation after argon laser trabeculoplasty. Doc Ophthalmol 1994; 85: 287-93.
38. Hurvitz LM, Spaeth GL, Zakhour I, Mahmood E, Murray G. A comparison of the effect of flurbiprofen, dexamethasone and placebo on cyclocryotherapy-induced inflammation. Ophthalmic Surg 1984; 15: 394-9.
39. Garry R. Ketorolac tromethamine: a non-steroidal anti-inflammatory agent for ophthalmic use in the management of ocular itching associated with seasonal allergic conjunctivitis. Allergan Technical Report 1993.
40. Tauber J, Abelson M, Ostrov C, Laibovitz R, Raizman M, Betts J, et al. A multicenter comparison of diclofenac sodium 0.1% to ketorolac tromethamine 0.5% in patients with acute seasonal allergic conjunctivitis. Invest Ophthalmol Vis Sci 1994; 35 (suppl): 1291.
41. Van Husen H. Topical treatment of anterior ocular diseases with diclofenac Na eye drops. Klin Monatsbl Augenheilkd 1986; 188: 615-9.
42. Murphy JE. Drug profile: Tanderil eye ointment. J Int Med Res 1973; 1: 136-40.
43. Rushford WAI, Holman RM, Pulvertaft TB. Tanderil/Chloramphenicol eye ointment in the treatment of the 'Red eye' seen in general practice. J Int Med Res 1978; 6: 141-3.
44. Emery DG, Smith VH, Wilkinson P. A trial of oxyphenbutazone eye ointment in general practice. Practitioner 1973; Dec: 3-7.
45. Gimbel HV. The effect of treatment with topical nonsteroidal anti-inflammatory drugs with and without intra-operative epinephrine on the maintenance of pupillary mydriasis during cataract surgery. Ophthalmology 1989; 96: 585-8.
46. Bonomi L, Totolo G, Marchini G, Rigotti P, Ghini M. Prevention of trauma induced miosis during cataract extraction by diclofenac sodium. New Trends in Ophthalmology 1987; 2: 512-8.
47. Goa KL, Chrisp P. Ocular diclofenac: a review of its pharmacology and clinical use in cataract surgery and potential in other inflammatory ocular conditions. Drugs Aging 1992; 2: 480.
48. Psilas K, Kalogeropoulos C, Loucatzicos E, Asproudis I, Petroutsos G. The effect of indomethacin, diclofenac and flurbiprofen on the maintenance of mydriasis during extracapsular cataract extraction. Doc Ophthalmol 1992; 81: 293-300.
49. Norton AL, Brown WJ, Carson M. Pathogenesis of aphakic macular edema. Am J Ophthalmol 1975; 80: 86-101.
50. Obstbaum SA, Galin MA. Cystoid macular edema and ocular inflammation. The corneo-retinal inflammatory syndrome. Trans Ophthalmol Soc UK 1979; 99: 187-91.
51. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic cystoid macular edema: five randomised trials. J Am Intraocul Implant Soc 1985; 11: 380-5.
52. Abelson MB, Parver L. How to handle CME in pseudophakes. Rev Ophthalmol 1994; Oct: 138-9.
53. Miyake K, Sakamura S, Muira H. Long-term follow-up study on the prevention of aphakic cystoid macular edema by topical indomethacine. Br J Ophthalmol 1980; 64: 324-8.
54. Yannuzzi LA, Landau AN, Turtz AL. Incidence of aphakic cystoid macular edema with the use of topical indomethacine. Ophthalmology 1981; 88: 947-54.
55. Kraff MC, Sanders DR, Jampol LM, Peyman GA, Lieberman HL. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 1982; 89: 885-90.
56. Quentin CD, Behrens-Baumann W, Gaus W. Prophylactic treatment of cystoid macula oedema with diclofenac eye drops in intracapsular cataract extraction with the Choyce Mark IX anterior chamber lens. Fortschr Ophthalmol 1989; 86: 546-9.
57. Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids. Ophthalmology 1990; 97: 1253-8.
58. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. J Cataract Refract Surg 1995; 21: 73-81.
59. Ginsburg AP, Cheetham JK, DeGryse RE, Abelson M. Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: functional vision and contrast sensitivity. J Cataract Refract Surg 1995; 21: 82-92.
60. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular oedema. Am J Ophthalmol 1987; 103: 479-86.
61. Peterson M, Yoshizumi MO, Hepler R, Mondino B, Krieger A. Topical indomethacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1992; 230: 401-5.
62. Burnett J, Tessler H, Isenberg S, Tso MO. Double-masked trial of fenoprofen sodium: treatment of chronic aphakic cystoid macular edema. Ophthalmic Surg 1983; 14: 150-2.
63. Drolsum L, Haaskjold E. Causes of decreased visual acuity after cataract extraction. J Cataract Refract Surg 1995; 21: 59-63.
64. Ishikawa T, del Cerro M, Liang FQ, Kim JC, Aquavella JV. Hypersensitivity following excimer laser ablation through the corneal epithelium. Refract Corneal Surg 1992; 8: 466-74.
65. Szerenyi K, Sorken K, Garbus JJ, Lee M, Mc Donnell PJ. Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 1994; 118: 312-5.
66. Kaidman GW. Diclofenac and its effect on corneal sensation. Arch Ophthalmol 1995; 113: 262.
67. Harr D. PRK: no pain, major gain. Ocular Surg News 1992; 21: 73-1.
68. Sher NA, Frantz JM, Talley A, Parker P, Lane SS, Ostrov C, et al. Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. Refract Corneal Surg 1993; 9: 425-36.
69. Ekdahl J. Promising use of non-steroidals with PRK. Eyecare Technology 1994; 4: 58-105.
70. Stein R, Stein HA, Cheskes A, Symons S. Photorefractive keratectomy and post-operative pain. Am J Ophthalmol 1994; 117: 403-5.
71. Donnenfeld ED, Selkin BA, Perry HD, Moadel K, Selkin GT, Cohen AJ, et al. Controlled evaluation a bandage contact lens and a topical non-steroidal anti-inflammatory drug in treating traumatic corneal abrasions. Ophthalmology 1995; 102: 979-84.
72. Epstein RL, Laurence EP. Relative effectiveness of topical ketorolac and topical diclofenac on discomfort after radial keratotomy. J Cataract Refract Surg 1995; 21: 156-9.
73. Hoh H. Local anaesthetic effect and subjective tolerance of 0.5% levobunolol in normal eyes. Klin Monatsbl Augenheilkd 1990; 1: 20-6.
74. Kulkarni PS, Srinivasan BD. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva [Review]. Progr Clin Biol Res 1989; 312: 39-52.
75. Phillips AF, Szerenyi K, Campos M, Krueger RR, McDonnell PJ. Arachidonic acid metabolites after excimer laser corneal surgery. Arch Ophthalmol 1993; 111: 1273-8.
76. Szerenyi KD, Campos M, McDonnell PJ. Prostaglandin E2 production after lamellar keratectomy and photorefractive keratectomy. J Refract Corneal Surg 1994; 10: 413-6.
77. Hanson DL, DeLeo VA. Long wave ultraviolet radiation stimulates arachidonic acid release and cyclooxygenase activity in mammalian cell culture. Photochem Photobiol 1989; 49: 423-30.
78. Levine JD, Gooding J, Donatoni P, Borden L, Goetzl EJ. The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci 1985; 5: 3025-9.
79. Szerenyi K, Wang XW, Lee M, Mc Donnell PJ. Topical diclofenac treatment prior to excimer laser photorefractive keratectomy in rabbits. Refract Corneal Surg 1993; 9: 437-12.
80. Perianin A, Gougerot-Pocidalo MA, Giroud JP, Hakim J. Diclofenac sodium, a negative chemokinetic factor for neutrophil locomotion. Biochem Pharmacol 1985; 34: 3433-8.
81. Srinivasan BD, Kulkarni PS. Polymorphonuclear leukocyte response. Inhibition following corneal epithelial denudation by steroidal and non-steroidal anti-inflammatory agents. Arch Ophthalmol 1981; 99: 1085-9.
82. Leibowitz HM, Ryan WJ, Kupferman A, De Santis L. Effect of concurrent topical corticosteroid and NSAID therapy of experimental keratitis. Invest Ophthalmol Vis Sci 1986; 27: 1226-9.
83. Arshinoff S, D'Addario D, Sadler C, Bilotta R, Johnson TM. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994; 20 (suppl): 216-22.
84. Napoli SA, Helm C, Insler MS, Ensley HE, Pretus HA, Feigen LP. External ocular inflammatory effects of lipoxygenase enzyme products. Ann Ophthalmol 1990; 22: 30-4.
85. Palmer RM, Stepney RJ, Higgs GA, Eakins KE. Chemokinetic activity of arachidonic acid lipogenase products on leukocytes of different species. Prostaglandins 1980; 20: 411-7.
86. Stjernschantz J. Autocoids and neuropeptides. In: Sears ML, ed. Pharmacology of the eye. New York: Springer-Verlag, 1984: 311.
87. Johnson D, Aston J. Issues and answers in excimer laser PRK. Rev Ophthalmol 1994; 7: 84-93.
88. Ferrari M. Use of topical non-steroidal anti-inflammatory drugs after photorefractive keratectomy. J Refract Corneal Surg 1994; 10 (2 suppl): S287-9.
89. Nassaralla BA, Szerenyi K, Wang XW, Al Reaves T, McDonnall PJ. Effect of diclofenac on corneal haze after photorefractive keratectomy in rabbits. Ophthalmology 1995; 102: 469-74.
90. Frew A. Selected side effects: non-steroidal anti-inflammatory drugs and asthma. Prescribers' J 1994; 34: 2.
91. Voltarol ophtha. ABPI data sheet compendium 1995-6: 416-7.
92. Ocufen. ABPI data sheet compendium 1995-6: 74.
93. Serle JB. Pharmacological advances in the treatment of glaucoma. Drugs Aging 1994; 5: 157-70.
94. Bito LZ, Stjernschantz J, Resul B, Miranda OC, Basu S. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analogue, PhXA41 (latanoprost), for glaucoma management. J Lipid Mediators 1993; 6: 535-13.
95. Gum CG, Kingsbury S, Whitley RD, Garcia A, Gelatt KN. Effect of topical prostaglandin PGA2. PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes. J Ocular Pharmacol 1991; 7: 107-16.
96. Ando Y, Matsunami C, Yamamoto T, Kitazawa Y. Safety and ocular hypotensive effect of new prostaglandin analogue, S-1033, in normal volunteers. Acta Soc Ophthalmol Jap 1994; 98: 1109-14.
97. Sugrue MF, O'Neill-Davis L. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits. J Ocular Pharmacol 1991; 7: 201-11.
98. Trusopt Ophthalmic Solution 2% (dorzolamide hydrochloride). Merck Sharpe & Dohme Ltd, Data sheet 1995.